NEM vs REPL · P/E 14, rev $22.67B vs $825.7M cap
Newmont Goldcorp Corp (NEM) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported NEM revenue for 2025-12-31 was $22.67B. Net income was $7.08B. Revenue was up 21.3% from 2024-12-31 to 2025-12-31. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
REPL does not have a complete income-statement cache yet.
NEM currently screens at market cap $112.81B and trailing P/E 13.7. REPL currently screens at market cap $825.7M.
Not investment advice. Open the NEM and REPL stock pages for the full models.
Not investment advice.